top of page

Dalbergia lanceolaria subsp. paniculata: Medicinal Uses, Recipes and Formulations

2 hours ago
8 min read

Dalbergia paniculata, commonly known as Padru Pachhali or Patri, is a deciduous tree of the Fabaceae family whose documented medicinal value is centered on its antioxidant, anti-inflammatory, and antibacterial properties. It is a lesser-known species within a genus renowned for its timber and medicinal value, with the plant's phytochemistry dominated by isoflavonoids including biochanin A, genistein, dalpatein, and formononetin, alongside tannins, terpenoids, and saponins . The leaves and bark have demonstrated the most promising bioactivity, showing concentration-dependent antibacterial effects against pathogens including Staphylococcus aureus, Escherichia coli, and Proteus vulgaris, with minimum inhibitory concentrations as low as 2.5 mg/mL . The methanolic leaf extract has also demonstrated dose-dependent anti-inflammatory activity in carrageenan-induced rat paw edema, with the 800 mg/kg dose producing 47.83% inhibition . This monograph must be framed with a critical caveat: a Shodhganga review explicitly states that "there are no published pharmacological reports till now on this plant" beyond the limited studies available, and no human clinical trials have been identified for any indication . The evidence base is preliminary, preclinical, and largely confined to a handful of in vitro and animal studies.


Critical Note on the Evidence Base


The scientific literature on Dalbergia paniculata is sparse and fragmented. The available studies are limited to phytochemical screening , antibacterial assays , antioxidant and anti-inflammatory investigations in rats , and a pharmacognostic characterization including toxicity assessment . The Shodhganga review notes that while the Dalbergia genus possesses immense traditional application, "there are no published pharmacological reports till now on this plant" . A 2012 study on Egyptian-cultivated material isolated isoflavonoids and evaluated antioxidant activity , and a 2020 study on the subsp. paniculata (sometimes treated as Dalbergia lanceolaria subsp. paniculata) examined seed metabolites . No human clinical trials, no pharmacokinetic studies, and no ethnobotanical studies detailing specific traditional preparations or dosages have been identified. This monograph presents only what is directly documented, with clear attribution of the preliminary nature of each finding.


Medicinal Uses: Summary of Primary and Secondary Actions


Primary Actions


1. Antibacterial and Antimicrobial


Dalbergia paniculata demonstrates concentration-dependent antibacterial activity, with the leaf and bark extracts showing the most promise. A 2015 study screened methanolic extracts of leaf, bark, stem, and root against ten different pathogens. Leaf and bark extracts exhibited maximum antibacterial activity against Staphylococcus aureus, Proteus vulgaris, and Escherichia coli, with MIC values as low as 2.5 mg/mL. All extracts showed significant activity with MIC ranging from 10 to 2.5 mg/mL . The phytochemicals responsible include terpenoids, flavonoids, tannins, and coumarins, with terpenoids specifically noted as conferring antimicrobial properties and flavonoids contributing to both antioxidant and antimicrobial activity . This action supports the traditional use of the plant for wound infections and gastrointestinal infections, though no specific ethnobotanical documentation of these uses was found in the available sources.


2. Antioxidant and Anti-inflammatory


The methanolic leaf extract demonstrates dose-dependent antioxidant activity in superoxide radical, hydroxyl radical, and DPPH radical scavenging assays . In the carrageenan-induced rat paw edema model, all three tested doses (200, 400, and 800 mg/kg) produced significant inhibition of paw edema, with the 800 mg/kg dose producing maximum inhibition of 47.83% at 3 hours compared to control . A separate Shodhganga study on the hydro-alcoholic extract reported maximal percentage inhibition of paw edema of 41.30%, 49.33%, and 53.38% at 200, 400, and 800 mg/kg respectively, with the standard indomethacin producing 60.05% inhibition . The antioxidant and anti-inflammatory effects are attributed to the flavonoid content, particularly isoflavonoids such as biochanin A, genistein, dalpatein, and formononetin .


3. Phytochemical and Isoflavonoid Profile


The plant is phytochemically characterized by its isoflavonoid content. Four isoflavonoids were isolated from the chloroform-soluble part of the defatted ethanolic extract of the stem bark and leaves: biochanin A, genistein, dalpatein, and formononetin . Genistein was isolated from D. paniculata for the first time in this study . Other compounds isolated from various parts include caviunin and sitosterol from leaves, dalpanitin and dalpatin as isoflavonoid glycosides, dalpanol, and dalpaniculin from seeds . Three new isoflavonoid glycosides (8-C-glucosylprunetin and biochanin-A and formononetin 7-rutinosides) were isolated from the bark . These compounds are of pharmacological interest for their documented antioxidant, anti-inflammatory, and estrogenic activities.


Secondary Actions and Limited Evidence


No Verified Hepatoprotective or Antidiabetic Evidence: No studies on hepatoprotective or antidiabetic activity were identified for D. paniculata specifically. These activities are documented for other Dalbergia species but cannot be extrapolated without direct evidence.


No Verified Traditional Ethnomedicinal Uses: The Shodhganga review notes that the Dalbergia genus has immense traditional application but states "there are no published pharmacological reports till now on this plant" . No specific ethnobotanical uses for D. paniculata were detailed in the available sources.


Critical Safety Warning: Toxicity and Dosage


Acute toxicity studies conducted according to OECD guidelines provide preliminary safety data. The alcoholic extract of D. paniculata administered orally at 2000 mg/kg to albino Wistar rats showed neither visible signs of toxicity nor mortality. The results indicated non-toxicity at this dose, with no LD50 determined, and the extract was considered safe and non-toxic . A separate pharmacognostic study reported an LD50 of 173 (units not specified) for the alcoholic leaf extract, though this appears to be from a different study protocol .


However, several critical limitations must be noted. These acute toxicity studies are limited to a single high dose and do not establish safety for repeated or chronic use. No sub-chronic or chronic toxicity studies, no genotoxicity studies, and no reproductive toxicity studies have been identified. The plant contains isoflavonoids including genistein and biochanin A, which possess estrogenic activity . This raises theoretical concerns for individuals with hormone-sensitive conditions and for use during pregnancy. The plant's use during pregnancy and lactation has not been studied and should be avoided without professional guidance. No human safety data exist.


Medicinal Parts


Leaves: The leaves are the most extensively studied medicinal part. The methanolic leaf extract demonstrated significant antioxidant and anti-inflammatory activity in rats . Leaf extracts showed the strongest antibacterial activity alongside bark, with MIC values as low as 2.5 mg/mL against S. aureus, P. vulgaris, and E. coli . The leaves contain isoflavonoids including biochanin A, genistein, dalpatein, and formononetin .


Bark: The bark is a primary source of isoflavonoids and demonstrated antibacterial activity comparable to the leaves . The stem bark yielded the isoflavonoids biochanin A, genistein, dalpatein, and formononetin in the Egyptian study , and three new isoflavonoid glycosides were isolated from the bark . Saponins were found to be present in bark and root extracts .


Seeds: Seeds yielded dalpaniculin, a C-glycosylisoflavone, along with other compounds . The seed extract has been studied for antioxidant activity, with the methanol extract exhibiting strong DPPH radical scavenging (IC50 0.7 µg/µl) . However, the seeds are not a primary medicinal part in the available literature.


Phytochemistry


1. Isoflavonoids (Leaves, Bark, Seeds)


This is the signature chemical class of Dalbergia paniculata. Biochanin A, genistein, dalpatein, and formononetin were isolated from the stem bark and leaves . Genistein was isolated from this species for the first time in the Egyptian study . Dalpaniculin, a C-glycosylisoflavone, was isolated from seeds . These compounds are responsible for the antioxidant, anti-inflammatory, and potential estrogenic activities of the plant.


2. Terpenoids, Tannins, and Saponins (Leaves, Bark, Root)


Phytochemical screening revealed the presence of terpenoids, tannins, saponins, coumarins, and steroids . Terpenoids are noted as conferring antimicrobial properties, while tannins contribute to the plant's astringent and antimicrobial effects . Saponins were found in bark and root extracts .


3. Alkaloids (Absent)


Both the 2015 study and the earlier Shodhganga review confirm that alkaloids were found to be absent in D. paniculata .


Mechanisms of Action


1. Antibacterial Action: Phytochemical-Mediated Inhibition


The antibacterial mechanism is attributed to the combined action of terpenoids, flavonoids, tannins, and coumarins, which disrupt bacterial membrane integrity, inhibit cell wall synthesis, and interfere with essential metabolic enzymes . The concentration-dependent activity observed in the MIC assays indicates a dose-response relationship, with higher concentrations producing greater inhibition .


2. Anti-inflammatory Action: Flavonoid-Mediated Inhibition


The anti-inflammatory mechanism is likely mediated by the isoflavonoids, which inhibit pro-inflammatory signaling pathways. The dose-dependent inhibition of carrageenan-induced paw edema suggests suppression of prostaglandin synthesis and other inflammatory mediators . The specific molecular targets have not been elucidated.


3. Antioxidant Action: Free Radical Scavenging


The antioxidant mechanism involves direct scavenging of superoxide, hydroxyl, and DPPH radicals by the phenolic and flavonoid compounds, particularly the isoflavonoids . The hydro-alcoholic extract showed significant activity, with IC50 values for superoxide and DPPH radical scavenging of 80.24 µg and 60.24 µg respectively .


Clinical Significance and Evidence Summary


1. Evidence Hierarchy by Activity


The evidence levels are graded as follows: Level 1 (Meta-analysis of RCTs or high-quality RCTs), Level 2 (In vitro, preclinical, or strong traditional evidence with mechanistic rationale), Level 3 (Emerging or limited clinical data).


Antibacterial: Level 2. In vitro evidence demonstrating concentration-dependent activity against S. aureus, P. vulgaris, and E. coli, with MIC values as low as 2.5 mg/mL .


Anti-inflammatory: Level 2. Preclinical evidence in carrageenan-induced rat paw edema, with dose-dependent inhibition reaching 47.83% to 53.38% at 800 mg/kg .


Antioxidant: Level 2. In vitro evidence of superoxide, hydroxyl, and DPPH radical scavenging activity .


Toxicity: Level 2 (Limited). Acute toxicity study showing no mortality or visible signs of toxicity at 2000 mg/kg orally in rats .


2. Study Limitations and Research Needs


The evidence base for Dalbergia paniculata is extremely limited and preliminary. The critical gaps are: the complete absence of human clinical trials; the absence of sub-chronic and chronic toxicity studies; the absence of pharmacokinetic data; the absence of ethnobotanical documentation of specific traditional uses, preparations, or dosages; and the limited characterization of the full phytochemical profile. The Shodhganga review's statement that "there are no published pharmacological reports till now on this plant" underscores how nascent the research is . Priority research needs include: ethnobotanical fieldwork to document any traditional medicinal uses; activity-guided isolation to identify the specific compounds responsible for antibacterial and anti-inflammatory effects; in vivo studies with multiple dose levels and longer durations; and comprehensive toxicological evaluation.


Drug Interactions


No drug interaction studies have been conducted on Dalbergia paniculata. Given its isoflavonoid content (including genistein and biochanin A), theoretical considerations include potential additive effects with other antibacterial or anti-inflammatory agents. The estrogenic activity of the isoflavonoids raises a theoretical concern for interactions with hormonal therapies, though the clinical relevance is unknown . As with any uncharacterized plant preparation, individuals taking medications with narrow therapeutic indices should exercise caution and consult a healthcare practitioner before use.


Final Summary of Contraindications and Precautions


Absolute Contraindications:


· Known allergy to Dalbergia paniculata or other plants in the Fabaceae family.

· Pregnancy and breastfeeding, due to the presence of estrogenic isoflavonoids and the absence of safety data.


Use with Caution:


· Individuals with hormone-sensitive conditions, due to the estrogenic activity of genistein and related isoflavonoids .

· Individuals taking antibacterial or anti-inflammatory medications: theoretical additive effects.

· Any medicinal use: the evidence base is insufficient to support specific therapeutic recommendations. No human clinical trials exist.


Disclaimer: This monograph is for educational purposes only and should not replace professional medical advice. Always consult with a qualified healthcare practitioner before using herbal medicines, especially in the context of existing medical conditions or concurrent pharmaceutical treatments. The evidence for Dalbergia paniculata is preliminary and derived from a small number of in vitro and animal studies. No human clinical trials have established efficacy or safety for any medicinal indication. The Shodhganga review explicitly states that no published pharmacological reports exist on this plant beyond the limited studies available . Traditional uses should not be assumed to be clinically validated, and the plant should not replace standard medical care for any condition.

Comments

Rated 0 out of 5 stars.
No ratings yet

Add a rating
bottom of page